Tonix Pharmaceuticals Holding CORP.
Tonix Pharmaceuticals develops pharmaceutical products across multiple therapeutic areas including central nervous system disorders, infectious diseases, immunology, immuno-oncology, and rare diseases. The company has a pipeline of drug candidates designated by codes such as TNX-102 SL, TNX-1300, TNX-4800, TNX-801, TNX-4200, TNX-1500, TNX-1700, TNX-4700, and TNX-2900, and markets a product called TONMYA®. The company conducts clinical trials and research in areas including fibromyalgia, migraine, Lyme disease, mpox, smallpox, organ transplant rejection, gastro-intestinal cancers, and Prader-Willi syndrome.
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Tonix Pharmaceuticals Holding CORP. | Berkeley Heights | NJ | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.